Holdco Nuvo Group D.G Ltd. (NUVOQ) vs Nexalin Technology, Inc. (NXL)
- Holdco Nuvo Group D.G Ltd. NUVOQ 0.00 NaN
- Nexalin Technology, Inc. NXL 2.35 −4.08%
Holdco Nuvo Group D.G Ltd. and Nexalin Technology, Inc. are both Medical Devices companies. Nexalin Technology, Inc. is the larger, with a market value of $2.6M against $2.1M — 1.2× the size. Holdco Nuvo Group D.G Ltd. has the higher net margin (0.00% vs −4,138.5%) and the higher return on invested capital (0.00% vs −1,108.8%). Across the 12 metrics below, Holdco Nuvo Group D.G Ltd. leads on 9 and Nexalin Technology, Inc. on 3.
Valuation
Profitability
| Metric | NUVOQ | NXL | Medical Devices median |
|---|---|---|---|
| Gross margin | — | 86.14% | 56.01% |
| Operating margin | 0.00% | (4,201.66%) | (15.03%) |
| Net margin | 0.00% | (4,138.49%) | (20.40%) |
| Free cash flow margin | 0.00% | (2,917.96%) | (7.24%) |
| Return on equity | 63.38% | (240.25%) | (15.32%) |
| Return on assets | (930.47%) | (187.89%) | (19.72%) |
| Return on invested capital | 0.00% | (1,108.82%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack